Sahar Sheida, chief innovation officer at KOS, emphasized the importance of refining the company’s foundational processes, such as formulation and quality control, under the new ownership team. Sheida highlighted the goal of building on the trust established by KOS in the vegan protein market.
With the infrastructure set, Sheida expressed enthusiasm for the brand’s future, believing that the current period in nutrition is particularly dynamic. She aims to leverage KOS’s solid reputation to introduce sophisticated innovations.
Instead of viewing changes as merely corrective measures, KOS focuses on integrating formulation with manufacturing and sourcing. Sheida remarked that manufacturing plays a critical role in innovation, with product quality and stability considered from the start of development.
This strategy has facilitated KOS’s expansion into new areas such as creatine and microbiome health, driven by scientific research rather than trends. Their new product, Smart Creatine, reflects this strategy by enhancing physical and cognitive performance.
Sheida sees this expansion as an “evolution” for KOS, asserting that plant-based products can extend beyond just protein. Future innovations will focus on various aspects of health while maintaining consumer trust at the core of the company’s mission. Sheida aims for consumers to be pleasantly surprised by KOS’s offerings, confident in their scientific credibility and transparency.
